Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 04:00PM ET
18.06
Dollar change
-0.61
Percentage change
-3.27
%
Index- P/E- EPS (ttm)-1.53 Insider Own32.34% Shs Outstand131.66M Perf Week6.55%
Market Cap2.38B Forward P/E- EPS next Y-1.55 Insider Trans-1.49% Shs Float89.08M Perf Month11.90%
Income-162.05M PEG- EPS next Q-0.42 Inst Own51.12% Short Float2.74% Perf Quarter23.87%
Sales6.91M P/S344.11 EPS this Y1.99% Inst Trans38.67% Short Ratio3.59 Perf Half Y98.90%
Book/sh3.79 P/B4.76 EPS next Y-0.73% ROA-32.83% Short Interest2.44M Perf Year161.74%
Cash/sh3.94 P/C4.59 EPS next 5Y- ROE-42.73% 52W Range6.15 - 18.77 Perf YTD126.88%
Dividend Est.- P/FCF- EPS past 5Y- ROI-27.78% 52W High-3.78% Beta1.53
Dividend TTM- Quick Ratio21.52 Sales past 5Y0.00% Gross Margin86.07% 52W Low193.66% ATR (14)1.01
Dividend Ex-Date- Current Ratio21.52 EPS Y/Y TTM7.72% Oper. Margin-2350.25% RSI (14)58.10 Volatility4.73% 6.88%
Employees76 Debt/Eq0.17 Sales Y/Y TTM- Profit Margin-2344.26% Recom1.00 Target Price28.57
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q6.97% Payout- Rel Volume0.97 Prev Close18.67
Sales Surprise- EPS Surprise6.64% Sales Q/Q- EarningsNov 12 BMO Avg Volume679.01K Price18.06
SMA204.52% SMA509.96% SMA20047.33% Trades Volume657,560 Change-3.27%
Date Action Analyst Rating Change Price Target Change
Sep-20-24Upgrade Morgan Stanley Equal-Weight → Overweight $11 → $26
Sep-19-24Initiated B. Riley Securities Buy $33
Jul-18-24Initiated Oppenheimer Outperform $14
Nov-15-23Upgrade Jefferies Hold → Buy $4 → $11
Oct-26-23Upgrade Morgan Stanley Underweight → Equal-Weight $4 → $8
Jun-21-23Initiated Evercore ISI Outperform
Jun-12-23Initiated Guggenheim Buy $9
Mar-17-23Initiated SVB Securities Outperform $6
Aug-12-22Downgrade Morgan Stanley Overweight → Underweight $10 → $5
Jun-17-22Initiated BMO Capital Markets Outperform $19
Nov-13-24 06:15AM
Nov-12-24 07:00AM
Nov-04-24 07:30AM
Oct-12-24 10:18AM
Oct-09-24 08:04AM
06:00AM Loading…
Sep-26-24 06:00AM
Sep-12-24 10:34PM
Sep-11-24 04:04PM
Sep-10-24 04:34PM
12:19PM
11:18AM
08:15AM
07:00AM
Aug-27-24 08:00AM
Aug-24-24 01:18AM
08:00AM Loading…
Aug-21-24 08:00AM
Aug-13-24 07:00AM
Jul-16-24 09:55AM
Jun-13-24 09:00AM
Jun-10-24 07:00AM
May-28-24 09:35AM
May-21-24 08:45AM
May-13-24 09:54PM
04:10PM
Apr-24-24 04:47AM
Apr-23-24 09:36PM
06:00PM
04:17PM
Apr-22-24 07:00AM
Mar-28-24 11:53PM
06:11PM Loading…
06:11PM
04:28PM
Mar-27-24 01:26AM
Mar-18-24 08:01PM
Feb-22-24 08:00AM
Feb-09-24 07:00AM
Jan-22-24 08:00AM
Dec-13-23 08:00AM
Dec-10-23 12:05PM
Dec-05-23 09:55AM
Nov-27-23 04:15PM
Nov-16-23 09:55AM
Nov-14-23 07:28PM
Nov-13-23 04:05PM
Nov-02-23 09:09AM
Oct-31-23 08:00AM
Oct-30-23 08:00AM
Oct-25-23 08:00AM
Oct-03-23 08:00AM
Sep-04-23 10:51AM
Aug-31-23 08:00AM
Aug-23-23 05:08PM
Aug-14-23 07:00AM
Jul-10-23 08:00AM
May-24-23 08:00AM
May-22-23 07:00AM
May-12-23 07:00AM
Apr-27-23 12:07PM
Mar-30-23 07:00AM
Mar-27-23 08:00AM
Mar-23-23 04:30PM
08:32AM
Mar-01-23 08:00AM
Feb-06-23 08:00AM
Feb-02-23 08:00AM
Jan-26-23 09:08AM
Dec-10-22 03:30PM
Nov-30-22 08:00AM
Nov-18-22 10:29AM
Nov-10-22 07:00AM
Nov-03-22 09:04AM
Oct-31-22 08:00AM
Sep-20-22 08:33AM
Sep-14-22 09:00AM
Sep-12-22 07:00AM
Aug-29-22 08:00AM
Aug-10-22 08:37AM
06:30AM
Jul-29-22 05:00AM
Jul-25-22 08:00AM
Jul-01-22 08:40AM
Jun-23-22 09:55AM
Jun-17-22 02:35PM
Jun-11-22 10:06AM
Jun-06-22 08:00AM
Jun-05-22 07:00AM
Jun-03-22 08:29AM
Jun-02-22 06:29AM
May-16-22 07:00AM
Mar-30-22 04:01PM
Mar-23-22 04:30PM
Mar-07-22 07:30AM
Feb-24-22 07:30AM
Feb-17-22 02:38AM
Jan-01-22 07:33AM
Dec-21-21 06:38PM
Dec-14-21 07:30AM
Dec-13-21 04:15PM
Dec-06-21 05:00PM
Nov-24-21 06:59AM
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAHA SAURABHChief Executive OfficerDec 06 '24Option Exercise5.8487,496510,977663,157Dec 06 05:03 PM
SAHA SAURABHChief Executive OfficerDec 06 '24Sale18.4687,4961,615,255575,661Dec 06 05:03 PM
SAHA SAURABHOfficerDec 06 '24Proposed Sale18.4687,4961,615,255Dec 06 04:14 PM
SAHA SAURABHChief Executive OfficerNov 25 '24Option Exercise5.842991,746575,960Nov 27 04:22 PM
SAHA SAURABHChief Executive OfficerNov 25 '24Sale18.232995,451575,661Nov 27 04:22 PM
Weinhoff Gregory MChief Business OfficerNov 25 '24Option Exercise3.8510,00038,500193,266Nov 27 04:20 PM
Weinhoff Gregory MChief Business OfficerNov 25 '24Sale17.6610,000176,601183,266Nov 27 04:20 PM
Weinhoff Gregory MOfficerNov 25 '24Proposed Sale17.3910,000173,900Nov 25 04:07 PM
SAHA SAURABHOfficerNov 25 '24Proposed Sale34.9529910,451Nov 25 04:03 PM
SAHA SAURABHChief Executive OfficerNov 21 '24Option Exercise5.843,51120,504579,172Nov 22 05:06 PM
SAHA SAURABHChief Executive OfficerNov 22 '24Option Exercise5.841,6719,759577,332Nov 22 05:06 PM
SAHA SAURABHChief Executive OfficerNov 20 '24Sale16.8955,000928,719575,661Nov 22 05:06 PM
SAHA SAURABHChief Executive OfficerNov 21 '24Sale18.243,51164,028575,661Nov 22 05:06 PM
SAHA SAURABHChief Executive OfficerNov 22 '24Sale18.241,67130,478575,661Nov 22 05:06 PM
SAHA SAURABHOfficerNov 22 '24Proposed Sale18.231,67130,462Nov 22 04:03 PM
SAHA SAURABHOfficerNov 21 '24Proposed Sale18.243,51164,028Nov 21 04:33 PM
SAHA SAURABHOfficerNov 20 '24Proposed Sale16.9755,000933,350Nov 20 04:03 PM
SAHA SAURABHChief Executive OfficerNov 13 '24Option Exercise5.8432,023187,014662,684Nov 15 04:30 PM
SAHA SAURABHChief Executive OfficerNov 13 '24Sale18.2832,023585,419630,661Nov 15 04:30 PM
SAHA SAURABHOfficerNov 13 '24Proposed Sale18.2832,023585,418Nov 13 04:18 PM
Weinhoff Gregory MChief Business OfficerOct 25 '24Sale15.3811,742180,628183,266Oct 25 07:19 PM
Weinhoff Gregory MOfficerOct 25 '24Proposed Sale15.5711,742182,822Oct 25 04:10 PM
SAHA SAURABHChief Executive OfficerOct 22 '24Sale15.6730,203473,169633,253Oct 23 05:27 PM
SAHA SAURABHChief Executive OfficerOct 21 '24Sale15.8022,205350,861663,456Oct 23 05:27 PM
SAHA SAURABHChief Executive OfficerOct 23 '24Sale15.322,59239,697630,661Oct 23 05:27 PM
SAHA SAURABHOfficerOct 23 '24Proposed Sale15.462,59240,072Oct 23 04:07 PM
SAHA SAURABHOfficerOct 22 '24Proposed Sale15.6730,203473,169Oct 22 04:15 PM
SAHA SAURABHOfficerOct 21 '24Proposed Sale15.8022,205350,861Oct 21 04:55 PM
Weinhoff Gregory MChief Business OfficerSep 25 '24Sale15.6916,619260,724206,750Sep 27 04:15 PM
Weinhoff Gregory MOfficerSep 25 '24Proposed Sale15.8016,619262,580Sep 25 04:01 PM
SAHA SAURABHChief Executive OfficerSep 20 '24Sale16.5355,000908,985721,924Sep 20 04:55 PM
SAHA SAURABHOfficerSep 20 '24Proposed Sale16.4555,000904,750Sep 20 04:01 PM
Weinhoff Gregory MChief Business OfficerSep 10 '24Option Exercise5.8430,000175,200253,369Sep 12 08:01 PM
Weinhoff Gregory MChief Business OfficerSep 10 '24Sale17.0030,000510,000223,369Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Option Exercise5.84175,0001,022,000951,924Sep 12 08:01 PM
SAHA SAURABHChief Executive OfficerSep 10 '24Sale16.52175,0002,891,822776,924Sep 12 08:01 PM
SAHA SAURABHOfficerSep 10 '24Proposed Sale16.52175,0002,891,822Sep 10 04:06 PM
Weinhoff Gregory MOfficerSep 10 '24Proposed Sale17.0030,000510,000Sep 10 04:04 PM
Weinhoff Gregory MChief Business OfficerSep 09 '24Option Exercise5.8425,000146,000248,369Sep 09 05:06 PM
Weinhoff Gregory MChief Business OfficerSep 09 '24Sale15.0025,000375,000223,369Sep 09 05:06 PM
Weinhoff Gregory MOfficerSep 09 '24Proposed Sale15.0025,000375,000Sep 09 04:07 PM
SAHA SAURABHChief Executive OfficerAug 23 '24Sale12.3046,651573,905776,924Aug 23 05:13 PM
Weinhoff Gregory MChief Business OfficerAug 23 '24Sale12.2917,802218,792223,369Aug 23 05:12 PM
Weinhoff Gregory MChief Business OfficerAug 22 '24Sale12.1712,198148,430241,171Aug 23 05:12 PM
Weinhoff Gregory MOfficerAug 23 '24Proposed Sale12.2917,802218,792Aug 23 04:19 PM
SAHA SAURABHOfficerAug 23 '24Proposed Sale12.3046,651573,905Aug 23 04:13 PM
SAHA SAURABHChief Executive OfficerAug 20 '24Sale12.324,16951,368827,755Aug 22 05:15 PM
SAHA SAURABHChief Executive OfficerAug 21 '24Sale12.253,67444,989824,081Aug 22 05:15 PM
SAHA SAURABHChief Executive OfficerAug 22 '24Sale12.235066,188823,575Aug 22 05:15 PM
Weinhoff Gregory MOfficerAug 22 '24Proposed Sale12.2412,198149,304Aug 22 04:32 PM
SAHA SAURABHOfficerAug 22 '24Proposed Sale12.235066,188Aug 22 04:13 PM
SAHA SAURABHOfficerAug 21 '24Proposed Sale12.253,67444,989Aug 21 04:38 PM
SAHA SAURABHOfficerAug 20 '24Proposed Sale12.324,16951,368Aug 20 04:52 PM
Anderson Karen M.Chief People OfficerMar 25 '24Option Exercise3.9445,000177,252122,685Mar 26 04:16 PM
Anderson Karen M.Chief People OfficerMar 25 '24Sale11.8851,160607,96071,525Mar 26 04:16 PM
Rotman HarrisSVP Regulatory AffairsFeb 01 '24Sale8.104,26734,57462,625Feb 02 05:03 PM